Programa de recomposición estética

This program offers a medical aesthetic protocol for weight loss and body recomposition over six months, involving a multidisciplinary team.

• The description claims that GLP-1 medications have changed how the world loses weight.
• The description claims that GLP-1 prescriptions increased 10 times globally in three years, with a 340% increase in Chile between 2022 and 2024.
• The description claims that rapid weight loss can lead to unwanted facial changes, muscle loss, localized fat, and temporary hair loss.
• The description claims that 68% of GLP-1 patients report undesired facial changes, about 20% of weight loss is muscle mass (sarcopenia), and there has been a 340% growth in GLP-1 prescriptions in Chile from 2022 to 2024.